ReviewAntibodies (Basel, Switzerland)2024

Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development.

Tsvetelina Velikova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.